Ultrahuman Healthcare Private Ltd. recently raised $35 million in a series B investment round to accelerate the company’s growth. Ultrahuman has developed several products, most notably a smart ring, which measures a range of physiological signals to impact health and wellbeing.
The U.S. FDA has posted another proposed ban of the use of electrical stimulation devices (ESDs) for the treatment of self-injurious behavior, which revisits the controversy over their use by the Judge Rotenberg Center.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Biodesix, Bio-Rad, Biosense Webster, Brain Trust Bio, Celle, Cryo-Cell, Daxor, Iso-Tex, J&J, Pathkeeper, Venus Concept.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adagio Medical, GE, Neuronetics, Lumenis Be.
Eledon Pharmaceuticals Inc.’s tegoprubart, an investigational anti-CD40 ligand antibody, was used as part of the immunosuppressive regimen after the first-ever transplant of a kidney from a genetically modified pig to a human. The tegoprubart procedure was done March 16 at Massachusetts General Hospital on a 62-year-old man with end-stage renal disease.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Elixir, Bio-Techne, Siemens Healthineers.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Axonics, Carterra, Cue Health, Immunoprecise Antibodies, Jiangsu Caina Medical, Jiangsu Shenli Medical, Lifeward, Medtronic, Naveris, Sol-Millennium.
RSS
